Literature DB >> 15518891

Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP.

Margalit Zusev1, Illana Gozes.   

Abstract

Activity-dependent neuroprotective protein (ADNP) was shown to be a vasoactive intestinal peptide (VIP) responsive gene in astrocytes derived from the cerebral cortex of newborn rats. The present study was set out to identify VIP receptors that are associated with increases in ADNP expression in developing astrocytes. Using VIP analogues specific for the VPAC1 and the VPAC2 receptors, it was discovered that VIP induced changes in ADNP expression in astrocytes via the VPAC2 receptor. The constitutive synthesis of ADNP and VPAC2 was shown to be age-dependent and increased as the astrocyte culture developed. Pituitary adenylate cyclase-activating polypeptide (PACAP) also induced changes in ADNP expression. The apparent changes induced by VIP and PACAP on ADNP expression were developmentally dependent, and while stimulating expression in young astrocytes, an inhibition was demonstrated in older cultures. In conclusion, VIP, PACAP and the VPAC2 receptor may all contribute to the regulation of ADNP gene expression in the developing astrocyte.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518891     DOI: 10.1016/j.regpep.2004.05.021

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  31 in total

1.  VIP-PACAP 2010: my own perspective on modulation of cognitive and emotional behavior.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2010-11       Impact factor: 3.444

Review 2.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  VIP, from gene to behavior and back: summarizing my 25 years of research.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

Review 4.  Neuroprotective protein and carboxypeptidase E.

Authors:  Hisatsugu Koshimizu; Vladimir Senatorov; Y Peng Loh; Illana Gozes
Journal:  J Mol Neurosci       Date:  2009-01-23       Impact factor: 3.444

5.  Mutations in ADNP affect expression and subcellular localization of the protein.

Authors:  Elisa Cappuyns; Jolien Huyghebaert; Geert Vandeweyer; R Frank Kooy
Journal:  Cell Cycle       Date:  2018-07-17       Impact factor: 4.534

6.  Differential regulation of vasoactive intestinal peptide (VIP) in the dentate gyrus and hippocampus via the NO-cGMP pathway following kainic acid-induced seizure in the rat.

Authors:  Anna Siobhan Cosgrave; Jennifer S McKay; Thimmasettappa Thippeswamy
Journal:  J Mol Neurosci       Date:  2010-04-06       Impact factor: 3.444

7.  Cycloheximide treatment to identify components of the transitional transcriptome in PACAP-induced PC12 cell differentiation.

Authors:  Aurélia Ravni; Lee E Eiden; Hubert Vaudry; Bruno J Gonzalez; David Vaudry
Journal:  J Neurochem       Date:  2006-06-19       Impact factor: 5.372

8.  ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance.

Authors:  Shmuel Mandel; Irit Spivak-Pohis; Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-02-20       Impact factor: 3.444

9.  Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.

Authors:  Eliezer Giladi; Joanna M Hill; Efrat Dresner; Conor M Stack; Illana Gozes
Journal:  J Mol Neurosci       Date:  2007-10-02       Impact factor: 3.444

10.  Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry.

Authors:  Joanna M Hill; Janet M Hauser; Lia M Sheppard; Daniel Abebe; Irit Spivak-Pohis; Michal Kushnir; Iris Deitch; Illana Gozes
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.